🇨🇦 DANYELZA in Canada

DANYELZA (NAXITAMAB-GQGK) regulatory status in Canada.

Marketing authorisation

DANYELZA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Canada

Frequently asked questions

Is DANYELZA approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for DANYELZA in Canada?

Y-MABS THERAPEUTICS INC is the originator. The local marketing authorisation holder may differ — check the official source linked above.